Hims & Hers Health reported growth in fourth-quarter sales, driven by higher subscription renewals and expanded product offerings. Management issued a subdued revenue outlook for the first quarter, citing slower new subscriber additions and increased marketing investments, which prompted a sell-off in the stock following the announcement.